Evidence map›Paper›PMID 26378160›Full record

ArticleJournal of virology2015

RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression.

Sanna M Mäkelä, Pamela Österlund, Veera Westenius, Sinikka Latvala, Michael S Diamond, Michael Gale, Ilkka Julkunen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Development and Effects of Influenza Antiviral Drugs.Molecules (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Respiratory Syncytial Virus's Non-structural Proteins: Masters of Interference.Frontiers in cellular and infection microbiology · 2020
    Review
  19. Article
  20. An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sanna M MäkeläViral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland sanna.makela@thl.fi.
Pamela ÖsterlundViral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland.
Veera WesteniusViral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland.
Sinikka LatvalaViral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland.
Michael S DiamondDepartments of Medicine, Pathology and Immunology, and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Michael GaleCenter for Innate Immunity and Immune Disease, Department of Immunology, University of Washington School of Medicine, Seattle, Washington, USA.
Ilkka JulkunenViral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland Department of Virology, University of Turku, Turku, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Washington · USWashington University in St. Louis · US

Funding

Innate Immune Control of West Nile VirusR01AI104002 · NIAID · UNIVERSITY OF WASHINGTON · PI DIAMOND, MICHAEL S, GALE, MICHAEL · 2013 to 2017
$3.7M
NIAID NIH HHS R01 AI104002
6 · The paper itself

Abstract

unlabelledInfluenza B virus causes annual epidemics and, along with influenza A virus, accounts for substantial disease and economic burden throughout the world. Influenza B virus infects only humans and some marine mammals and is not responsible for pandemics, possibly due to a very low frequency of reassortment and a lower evolutionary rate than that of influenza A virus. Influenza B virus has been less studied than influenza A virus, and thus, a comparison of influenza A and B virus infection mechanisms may provide new insight into virus-host interactions. Here we analyzed the early events in influenza B virus infection and interferon (IFN) gene expression in human monocyte-derived macrophages and dendritic cells. We show that influenza B virus induces IFN regulatory factor 3 (IRF3) activation and IFN-λ1 gene expression with faster kinetics than does influenza A virus, without a requirement for viral protein synthesis or replication. Influenza B virus-induced activation of IRF3 required the fusion of viral and endosomal membranes, and nuclear accumulation of IRF3 and viral NP occurred concurrently. In comparison, immediate early IRF3 activation was not observed in influenza A virus-infected macrophages. Experiments with RIG-I-, MDA5-, and RIG-I/MDA5-deficient mouse fibroblasts showed that RIG-I is the critical pattern recognition receptor needed for the influenza B virus-induced activation of IRF3. Our results show that innate immune mechanisms are activated immediately after influenza B virus entry through the endocytic pathway, whereas influenza A virus avoids early IRF3 activation and IFN gene induction. IMPORTANCE: Recently, a great deal of interest has been paid to identifying the ligands for RIG-I under conditions of natural infection, as many previous studies have been based on transfection of cells with different types of viral or synthetic RNA structures. We shed light on this question by analyzing the earliest step in innate immune recognition of influenza B virus by human macrophages. We show that influenza B virus induces IRF3 activation, leading to IFN gene expression after viral RNPs (vRNPs) are released into the cytosol and are recognized by RIG-I receptor, meaning that the incoming influenza B virus is already able to activate IFN gene expression. In contrast, influenza A (H3N2) virus failed to activate IRF3 at very early times of infection, suggesting that there are differences in innate immune recognition between influenza A and B viruses.

Indexed as

AnimalsCell LineDEAD Box Protein 58DEAD-box RNA HelicasesDendritic CellsGene Expression RegulationHost-Pathogen InteractionsHumansImmunoblottingInfluenza B virusInfluenza, HumanInterferon LambdaInterferon Regulatory Factor-3InterferonsInterleukinsMacrophagesDEAD Box Protein 58DEAD-box RNA HelicasesInterferon Lambdainterferon-lambda, humanInterferon Regulatory Factor-3InterferonsInterleukinsIRF3 protein, humanReceptors, ImmunologicRIGI protein, human

Identifiers

PMID26378160
PMCPMC4645339
OpenAlexW2243988213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.